Condition: X-linked Adrenoleukodystrophy · Sponsor: Minoryx Therapeutics, S.L.
Observational, single-site prospective and minimally interventional study in women with X-linked adrenoleukodystrophy (ALD), conducted in France.
This description comes directly from the study's public registry record.
Arun Mistry · +34935441466 · amistry@minoryx.com
Always discuss trial participation with your own doctor first.
| Paris Brain Institute (ICM) Centre Hospitalier Universitaire Pitié Salpêtrière | Paris, France | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06178120